MetaADEDB 2.0 @ LMMD
cabazitaxel
(BMQGVNUXMIRLCK-OAGWZNDDSA-N)
Structure
SMILES
CO[C@H]1C(=O)[C@]2(C)[C@@H](OC)C[C@@H]3[C@]([C@H]2[C@@H]([C@]2(C(C1=C(C)[C@@H](OC(=O)[C@@H]([C@H](c1ccccc1)NC(=O)OC(C)(C)C)O)C2)(C)C)O)OC(=O)c1ccccc1)(CO3)OC(=O)C
Type(s)
Approved
ATC code(s)
L01CD04
Molecular Formula:
C45H57NO14
Molecular Weight:
835.932
Log P:
4.9587
Hydrogen Bond Acceptor:
15
Hydrogen Bond Donor:
3
TPSA:
202.45
CAS Number(s):
183133-96-2
Synonym(s)
1.
cabazitaxel
2.
Jevtana
3.
kabazitaxel
External Link(s)
MeSHC552428
PubChem Compound9854073
ChEBI63584
CHEMBLCHEMBL1201748
DrugBankDB06772
DrugCentral4153
IUPHAR/BPS Guide to PHARMACOLOGY6798
KEGGdr:D09755
Therapeutic Target DatabaseD02HSB
ZINC85536932
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NeutropeniaFAERS: 27
Canada Vigilance: 8
Canada Vigilance
SIDER
US FAERS
2Febrile NeutropeniaFAERS: 26SIDER
US FAERS
3FatigueFAERS: 22
Canada Vigilance: 12
Canada Vigilance
SIDER
US FAERS
4VomitingFAERS: 17
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
5Disease ProgressionFAERS: 15
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
6PainFAERS: 14
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
7SepsisFAERS: 14
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
8Back PainFAERS: 13SIDER
US FAERS
9NauseaFAERS: 13
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
10PneumoniaFAERS: 13
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
11Septic ShockFAERS: 13
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
12AstheniaFAERS: 12
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
13Disseminated Intravascular CoagulationFAERS: 12US FAERS
14EpistaxisFAERS: 11US FAERS
15ExtravasationFAERS: 11US FAERS
16ConstipationFAERS: 10
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
17Neutrophil count decreasedFAERS: 10US FAERS
18HydronephrosisFAERS: 9SIDER
US FAERS
19Pulmonary EmbolismFAERS: 9US FAERS
20ThrombocytopeniaFAERS: 9SIDER
US FAERS
21PancytopeniaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
22Urinary tract infectionFAERS: 8
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
23AlopeciaFAERS: 7SIDER
US FAERS
24DysgeusiaFAERS: 7SIDER
US FAERS
25General physical health deteriorationFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
26PneumonitisFAERS: 7US FAERS
27SyncopeFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
28Abdominal PainFAERS: 6SIDER
US FAERS
29Acute kidney injuryFAERS: 6US FAERS
30DizzinessFAERS: 6
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
31HypotensionFAERS: 6SIDER
US FAERS
32IleusFAERS: 6SIDER
US FAERS
33Myocardial InfarctionFAERS: 6US FAERS
34Respiratory FailureFAERS: 6US FAERS
35StomatitisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
36Weight decreasedFAERS: 6
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
37ArthralgiaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
38AscitesFAERS: 5US FAERS
39Cardiac ArrestFAERS: 5SIDER
US FAERS
40DehydrationFAERS: 5
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
41Drug ineffectiveFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
42ErythemaFAERS: 5SIDER
US FAERS
43Unevaluable eventFAERS: 5US FAERS
44BronchitisFAERS: 4US FAERS
45Chest PainFAERS: 4SIDER
US FAERS
46DiverticulitisFAERS: 4US FAERS
47DysuriaFAERS: 4SIDER
US FAERS
48HypersensitivityFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
49InfectionFAERS: 4SIDER
US FAERS
50LeukopeniaFAERS: 4SIDER
US FAERS
51White blood cell count decreasedFAERS: 4US FAERS
52Acute Coronary SyndromeFAERS: 3US FAERS
53Blood lactate dehydrogenase increasedFAERS: 3US FAERS
54Bone painFAERS: 3US FAERS
55CellulitisFAERS: 3SIDER
US FAERS
56DiscomfortFAERS: 3SIDER
US FAERS
57EnteritisFAERS: 3US FAERS
58Febrile bone marrow aplasiaFAERS: 3US FAERS
59Gastric ulcerFAERS: 3US FAERS
60HaematotoxicityFAERS: 3US FAERS
61MalaiseFAERS: 3SIDER
US FAERS
62MetastasisFAERS: 3US FAERS
63Neutropenic infectionFAERS: 3US FAERS
64OnycholysisFAERS: 3US FAERS
65Product dose omissionFAERS: 3US FAERS
66Prostatic specific antigen decreasedFAERS: 3
Canada Vigilance: 6
Canada Vigilance
US FAERS
67TuberculosisFAERS: 3US FAERS
68AbscessFAERS: 2US FAERS
69AgeusiaFAERS: 2US FAERS
70AnuriaFAERS: 2US FAERS
71Atrial FibrillationFAERS: 2SIDER
US FAERS
72Blood alkaline phosphatase increasedFAERS: 2US FAERS
73Blood potassium increasedFAERS: 2US FAERS
74Cerebral InfarctionFAERS: 2US FAERS
75Cerebrovascular accidentFAERS: 2US FAERS
76CholestasisFAERS: 2US FAERS
77ColitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
78Deep Vein ThrombosisFAERS: 2SIDER
US FAERS
79DeliriumFAERS: 2US FAERS
80Facial paralysisFAERS: 2US FAERS
81FlatulenceFAERS: 2US FAERS
82Fluid overloadFAERS: 2US FAERS
83FlushingFAERS: 2
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
84Gamma-Glutamyltransferase IncreasedFAERS: 2US FAERS
85HemiplegiaFAERS: 2US FAERS
86HypoxiaFAERS: 2US FAERS
87Injection site extravasationFAERS: 2US FAERS
88Intestinal PerforationFAERS: 2US FAERS
89Large intestine perforationFAERS: 2US FAERS
90LeukocytosisFAERS: 2US FAERS
91Malignant neoplasm progressionFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
92MeningitisFAERS: 2US FAERS
93MyalgiaFAERS: 2
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
94OverdoseFAERS: 2US FAERS
95ParaplegiaFAERS: 2US FAERS
96Performance status decreasedFAERS: 2US FAERS
97PolyuriaFAERS: 2US FAERS
98ProctitisFAERS: 2US FAERS
99Productive CoughFAERS: 2US FAERS
100Pulmonary HypertensionFAERS: 2US FAERS
101Renal ColicFAERS: 2SIDER
US FAERS
102Respiratory arrestFAERS: 2US FAERS
103Skin irritationFAERS: 2US FAERS
104SomnolenceFAERS: 2US FAERS
105Sudden deathFAERS: 2US FAERS
106ThrombosisFAERS: 2US FAERS
107Urinary RetentionFAERS: 2SIDER
US FAERS
108VertigoFAERS: 2SIDER
US FAERS
109Wrong technique in product usage processFAERS: 2US FAERS
110jaundiceFAERS: 2US FAERS
111AbasiaFAERS: 1US FAERS
112Abdominal discomfortFAERS: 1US FAERS
113Accidental overdoseFAERS: 1
Canada Vigilance: 10
Canada Vigilance
US FAERS
114Activities of daily living impairedFAERS: 1US FAERS
115Acute Lung InjuryFAERS: 1US FAERS
116Acute myocardial infarctionFAERS: 1US FAERS
117Adverse eventFAERS: 1US FAERS
118AgranulocytosisFAERS: 1US FAERS
119AlveolitisFAERS: 1US FAERS
120Amylase increasedFAERS: 1US FAERS
121Anal FistulaFAERS: 1US FAERS
122Angina PectorisFAERS: 1US FAERS
123Application site extravasationFAERS: 1US FAERS
124AsphyxiaFAERS: 1US FAERS
125AtaxiaFAERS: 1US FAERS
126Atrial FlutterFAERS: 1US FAERS
127Atrioventricular BlockFAERS: 1US FAERS
128Bacterial sepsisFAERS: 1US FAERS
129Bladder NeoplasmFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
130Bladder painFAERS: 1SIDER
US FAERS
131Blood fibrinogen decreasedFAERS: 1US FAERS
132Blood parathyroid hormone increasedFAERS: 1US FAERS
133Blood sodium decreasedFAERS: 1US FAERS
134Blood urine presentFAERS: 1US FAERS
135Bone lesionFAERS: 1US FAERS
136Bone marrow infiltrationFAERS: 1US FAERS
137Burning sensationFAERS: 1US FAERS
138CachexiaFAERS: 1US FAERS
139Candida sepsisFAERS: 1US FAERS
140CardiotoxicityFAERS: 1US FAERS
141Cell marker increasedFAERS: 1US FAERS
142Central nervous system lesionFAERS: 1US FAERS
143Chest discomfortFAERS: 1US FAERS
144ChillsFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
145CholangitisFAERS: 1US FAERS
146CholecystitisFAERS: 1US FAERS
147ChromaturiaFAERS: 1US FAERS
148Colonic fistulaFAERS: 1US FAERS
149Deafness NeurosensoryFAERS: 1US FAERS
150Decreased immune responsivenessFAERS: 1US FAERS
151Device malfunctionFAERS: 1US FAERS
152Device related infectionFAERS: 1US FAERS
153Diabetic metabolic decompensationFAERS: 1US FAERS
154DiplopiaFAERS: 1US FAERS
155DisabilityFAERS: 1US FAERS
156Disease complicationFAERS: 1US FAERS
157DisorientationFAERS: 1US FAERS
158Diverticular perforationFAERS: 1US FAERS
159Drug dispensing errorFAERS: 1US FAERS
160Duodenal UlcerFAERS: 1US FAERS
161DuodenitisFAERS: 1US FAERS
162Electrolyte imbalanceFAERS: 1SIDER
US FAERS
163EmbolismFAERS: 1US FAERS
164EnterocolitisFAERS: 1SIDER
US FAERS
165Eye BurnsFAERS: 1US FAERS
166Failure to ThriveFAERS: 1US FAERS
167Feeling abnormalFAERS: 1
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
168GastritisFAERS: 1SIDER
US FAERS
169GastroenteritisFAERS: 1US FAERS
170Gastrointestinal PainFAERS: 1SIDER
US FAERS
171Gastrointestinal motility disorderFAERS: 1US FAERS
172GingivitisFAERS: 1US FAERS
173GlomerulonephritisFAERS: 1US FAERS
174HeadacheFAERS: 1SIDER
US FAERS
175Helicobacter test positiveFAERS: 1US FAERS
176Hepatic EncephalopathyFAERS: 1US FAERS
177HepatitisFAERS: 1US FAERS
178Hepatobiliary neoplasmFAERS: 1US FAERS
179HepatomegalyFAERS: 1US FAERS
180HepatotoxicityFAERS: 1US FAERS
181Hypertensive crisisFAERS: 1US FAERS
182Impaired gastric emptyingFAERS: 1US FAERS
183Incorrect product administration durationFAERS: 1US FAERS
184Infectious colitisFAERS: 1US FAERS
185Infectious pleural effusionFAERS: 1US FAERS
186Infective spondylitisFAERS: 1US FAERS
187InflammationFAERS: 1US FAERS
188InfluenzaFAERS: 1SIDER
US FAERS
189Infusion Site ExtravasationFAERS: 1US FAERS
190Intestinal ObstructionFAERS: 1SIDER
US FAERS
191LethargyFAERS: 1SIDER
US FAERS
192Limb discomfortFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
193Lip swellingFAERS: 1US FAERS
194ListeriosisFAERS: 1US FAERS
195Medication ErrorFAERS: 1US FAERS
196Musculoskeletal PainFAERS: 1US FAERS
197Musculoskeletal chest painFAERS: 1SIDER
US FAERS
198Musculoskeletal stiffnessFAERS: 1US FAERS
199MyocarditisFAERS: 1US FAERS
200Nail toxicityFAERS: 1US FAERS
201NasopharyngitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
202Neck PainFAERS: 1US FAERS
203No adverse eventFAERS: 1US FAERS
204OphthalmoplegiaFAERS: 1US FAERS
205Optic NeuropathyFAERS: 1US FAERS
206Osteonecrosis of JawFAERS: 1US FAERS
207PancreatitisFAERS: 1US FAERS
208Pelvic venous thrombosisFAERS: 1US FAERS
209Pericardial effusionFAERS: 1US FAERS
210Perineal cellulitisFAERS: 1US FAERS
211Peripheral swellingFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
212Platelet TransfusionFAERS: 1US FAERS
213PleurisyFAERS: 1US FAERS
214PolyneuropathyFAERS: 1US FAERS
215PresyncopeFAERS: 1US FAERS
216Product container issueFAERS: 1US FAERS
217Product quality issueFAERS: 1US FAERS
218Product use complaintFAERS: 1US FAERS
219Prostatic painFAERS: 1US FAERS
220Pubic painFAERS: 1US FAERS
221Pulmonary congestionFAERS: 1US FAERS
222Pulmonary sepsisFAERS: 1US FAERS
223PyelonephritisFAERS: 1US FAERS
224Pyoderma GangrenosumFAERS: 1US FAERS
225Renal painFAERS: 1US FAERS
226Respiratory distressFAERS: 1US FAERS
227Right ventricular failureFAERS: 1US FAERS
228ShockFAERS: 1US FAERS
229Skin lesionFAERS: 1US FAERS
230Skin necrosisFAERS: 1US FAERS
231StaringFAERS: 1US FAERS
232Stevens-Johnson SyndromeFAERS: 1US FAERS
233SwellingFAERS: 1US FAERS
234TachycardiaFAERS: 1SIDER
US FAERS
235Therapy cessationFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
236Therapy responderFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
237ThirstFAERS: 1US FAERS
238Throat irritationFAERS: 1US FAERS
239Tooth LossFAERS: 1US FAERS
240Transaminases increasedFAERS: 1SIDER
US FAERS
241Urge IncontinenceFAERS: 1US FAERS
242VIIth nerve paralysisFAERS: 1US FAERS
243Vitreous floatersFAERS: 1US FAERS
244White blood cell count abnormalFAERS: 1US FAERS
245Wound ComplicationFAERS: 1US FAERS
246Wrong technique in drug usage processFAERS: 1US FAERS
247Alanine Aminotransferase IncreasedSIDER
248AnorexiaSIDER
249AnxietySIDER
250Aspartate Aminotransferase IncreasedSIDER
251Blood and lymphatic system disordersSIDER
252Blood creatinine increasedCanada Vigilance: 1Canada Vigilance
253ConjunctivitisSIDER
254CystitisSIDER
255Dry skinSIDER
256DyspepsiaCanada Vigilance: 1Canada Vigilance
SIDER
257Ear and labyrinth disordersSIDER
258Flank PainSIDER
259InfestationSIDER
260MalnutritionSIDER
261Musculoskeletal discomfortSIDER
262Neutropenic colitisSIDER
263Neutropenic sepsisSIDER
264Oropharyngeal painSIDER
265Pelvic PainSIDER
266Product preparation issueCanada Vigilance: 10Canada Vigilance
267Prostatic Neoplasms22666205
24418724
CTD
268PruritusCanada Vigilance: 1Canada Vigilance
269SciaticaSIDER
270TinnitusSIDER
271Tongue erythemaCanada Vigilance: 1Canada Vigilance
272Urinary IncontinenceSIDER
273Ventricular FibrillationSIDER
274nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.